Matthew Eckler
Net worth: - $ as of 31/08/2026
Net worth: - $ as of 31/08/2026
Matthew Eckler currently works at Samsara Biocapital LLC, as Principal from 2025.
Dr. Eckler also formerly worked at RBC Capital Markets LLC, as Analyst from 2015 to 2018.
Dr. Eckler received his undergraduate degree in 2007 from The University of North Carolina at Chapel Hill and doctorate degree in 2013 from the University of California.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/10/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Director/Board Member | 01/10/2026 |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Private Equity Investor | 01/05/2025 |
| Companies | Position | End |
|---|---|---|
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/01/2018 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Select your edition
All financial news and data tailored to specific country editions